Zi-Ping Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zi-Ping Li has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Shi-Ting Feng
Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
23 shared publications Yanji Luo
Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 58th, The Second Zhongshan Road, Guangzhou, Guangdong 510080, China
13 shared publicationsHuasong Cai
Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 58th, The Second Zhongshan Road, Guangzhou, Guangdong 510080, China
12 shared publicationsZhi Dong
Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 58th, The Second Zhongshan Road, Guangzhou, Guangdong 510080, China
12 shared publicationsLing Xu
Faculty of Medicine and Dentistry, University of Western Australia, Perth, Australia
10 shared publications- Yanji Luo
Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, 58th, The Second Zhongshan Road, Guangzhou, 510080, Guangdong, China
6 shared publications
Latest Publications
- Open Access
- 22 January 2020
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge
Background: Hepatocellular carcinoma (HCC) with hilar bile duct tumor thrombus (HBDTT) often mimic hilar cholangiocarcinoma (hilar CC). The purpose of this study is to analyze the Computed Tomography (CT) characteristics of HCC with HBDTT and to identify imaging features to aid its differentiation from hilar CC on enhanced CT.Methods: We retrospectively identified 58 cases with pathologically proved HCC with HBDTT between 2011 and 2018. Seventy-seven cases of pathologically proven hilar CCs were selected during the same period. The clinical features and CT findings of the two groups were reviewed and compared.Results: HCC with HBDTTs are more commonly found in men (87.9% vs 63.6%,p = 0.001) with lower age of onset (49.84 vs 58.61 years;p < 0.001) in comparison to hilar CCs. Positive correlation were identified between HCC with HBDTTs and chronic HBV infection (72.4% vs 11.7%;p < 0.001), increased serum AFP (67.2% vs 1.3%;p < 0.001), CA19–9 level (58.6% vs 85.7%;p < 0.001) and CEA level (3.4% vs 29.9%;p = 0.001), parenchymal lesion with intraductal lesion (100% vs 18.2%;p < 0.001), washout during the portal venous phase (84.5% vs 6.5%;p < 0.001), thickened bile duct wall (8.6% vs 93.5%;p < 0.001), intrahepatic vascular embolus (44.8% vs 7.8%;p < 0.001), splenomegaly (34.5% vs 2.6%,p < 0.001). A scoring system consisting of the five parameters obtained from characteristics mentioned above was trialed. The sensitivity and specificity for diagnosing HCC with HBDTT were 96.39, 100 and 92.5% respectively when the total score was 2 or more.Conclusions: HCC with HBDTTs are often distinguishable from hilar CCs based on washout during portal venous phase without thickened bile duct wall. HBV infection and serum AFP level facilitate the differentiation.
- 22 January 2020
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Open AccessHepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge
Background: Hepatocellular carcinoma (HCC) with hilar bile duct tumor thrombus (HBDTT) often mimic hilar cholangiocarcinoma (hilar CC). The purpose of this study is to analyze the Computed Tomography (CT) characteristics of HCC with HBDTT and to identify imaging features to aid its differentiation from hilar CC on enhanced CT.Methods: We retrospectively identified 58 cases with pathologically proved HCC with HBDTT between 2011 and 2018. Seventy-seven cases of pathologically proven hilar CCs were selected during the same period. The clinical features and CT findings of the two groups were reviewed and compared.Results: HCC with HBDTTs are more commonly found in men (87.9% vs 63.6%,p = 0.001) with lower age of onset (49.84 vs 58.61 years;p < 0.001) in comparison to hilar CCs. Positive correlation were identified between HCC with HBDTTs and chronic HBV infection (72.4% vs 11.7%;p < 0.001), increased serum AFP (67.2% vs 1.3%;p < 0.001), CA19–9 level (58.6% vs 85.7%;p < 0.001) and CEA level (3.4% vs 29.9%;p = 0.001), parenchymal lesion with intraductal lesion (100% vs 18.2%;p < 0.001), washout during the portal venous phase (84.5% vs 6.5%;p < 0.001), thickened bile duct wall (8.6% vs 93.5%;p < 0.001), intrahepatic vascular embolus (44.8% vs 7.8%;p < 0.001), splenomegaly (34.5% vs 2.6%,p < 0.001). A scoring system consisting of the five parameters obtained from characteristics mentioned above was trialed. The sensitivity and specificity for diagnosing HCC with HBDTT were 96.39, 100 and 92.5% respectively when the total score was 2 or more.Conclusions: HCC with HBDTTs are often distinguishable from hilar CCs based on washout during portal venous phase without thickened bile duct wall. HBV infection and serum AFP level facilitate the differentiation.
- Open Access
- 17 July 2019
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2019, 1-10
Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules
Objectives. To assess the efficacy of diffusion kurtosis imaging (DKI) and compare DKI-derived parameters with conventional diffusion-weighted imaging (DWI) for distinguishing hepatocellular carcinoma (HCC) from benign hepatic nodules including focal nodular hyperplasia (FNH), hemangioma, and hepatocellular adenoma (HCA). Materials and Methods. 151 patients with 182 hepatic nodules (114 HCCs and 68 benign nodules including 33 FNHs, 29 hemangiomas, and 6 HCAs) were analyzed. Preoperative MRI examinations including DKI (b values: 0, 200, 500, 800, 1500, and 2000 sec/mm2) were performed, and kurtosis (K), diffusivity (D), and apparent diffusion coefficient (ADC) were calculated. The efficacy of DKI-derived parameters K, D, and ADC for distinguishing HCC from these benign nodules was analyzed. Results. ROC (receiver operating characteristic curve) analysis showed the optimal cutoff values of ADC, D, and K for identification of these benign nodules, and HCCs were 1.295 (area under the curve (AUC): 0.826; sensitivity 80.6%; specificity 70.8%), 1.787 (AUC: 0.770; sensitivity 83.6%; specificity 59.6%), and 1.002 (AUC: 0.761; sensitivity 65.5%; specificity 79.0%), respectively. Statistically significant differences were found in ADC, D, and K values between groups of HCC-FNH and HCC-hemangioma (). There were significant differences in K and ADC values between groups of FNH-hemangioma and HCA-hemangioma (), respectively. Using logistic regression analysis, a regression equation was obtained: (X1: ADC; X3: K), and odds ratios (OR) were 0.138 (95% confidence interval (CI): 0.052, 0.367), and 8.996 (95% CI: 0.970, 16.460), respectively. Conclusion. Both ADC value and DKI-derived parameters K and D values have demonstrated a higher preoperative efficacy in distinguishing HCC from FNH, hemangioma, and HCA. No evidence was shown to suggest D or K value was superior to the ADC value.- 17 July 2019
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2019, 1-10
Open AccessDiffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules
Objectives. To assess the efficacy of diffusion kurtosis imaging (DKI) and compare DKI-derived parameters with conventional diffusion-weighted imaging (DWI) for distinguishing hepatocellular carcinoma (HCC) from benign hepatic nodules including focal nodular hyperplasia (FNH), hemangioma, and hepatocellular adenoma (HCA). Materials and Methods. 151 patients with 182 hepatic nodules (114 HCCs and 68 benign nodules including 33 FNHs, 29 hemangiomas, and 6 HCAs) were analyzed. Preoperative MRI examinations including DKI (b values: 0, 200, 500, 800, 1500, and 2000 sec/mm2) were performed, and kurtosis (K), diffusivity (D), and apparent diffusion coefficient (ADC) were calculated. The efficacy of DKI-derived parameters K, D, and ADC for distinguishing HCC from these benign nodules was analyzed. Results. ROC (receiver operating characteristic curve) analysis showed the optimal cutoff values of ADC, D, and K for identification of these benign nodules, and HCCs were 1.295 (area under the curve (AUC): 0.826; sensitivity 80.6%; specificity 70.8%), 1.787 (AUC: 0.770; sensitivity 83.6%; specificity 59.6%), and 1.002 (AUC: 0.761; sensitivity 65.5%; specificity 79.0%), respectively. Statistically significant differences were found in ADC, D, and K values between groups of HCC-FNH and HCC-hemangioma (). There were significant differences in K and ADC values between groups of FNH-hemangioma and HCA-hemangioma (), respectively. Using logistic regression analysis, a regression equation was obtained: (X1: ADC; X3: K), and odds ratios (OR) were 0.138 (95% confidence interval (CI): 0.052, 0.367), and 8.996 (95% CI: 0.970, 16.460), respectively. Conclusion. Both ADC value and DKI-derived parameters K and D values have demonstrated a higher preoperative efficacy in distinguishing HCC from FNH, hemangioma, and HCA. No evidence was shown to suggest D or K value was superior to the ADC value. - 1 June 2019
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 9 (6) , 1076-1086
Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of visceral abdominal adiposity tissue volume
Background: The correlation between visceral adipose tissue volume (VATV), hepatic proton-density fat fraction (PDFF), and pancreatic PDFF has been previously studied to predict the presence of type 2 diabetes mellitus (T2DM). This study investigated VATV quantitation in patients with T2DM, prediabetes, and normal glucose tolerance (NGT) using MRI to assess the roles of VATV, hepatic, and pancreatic PDFF in predicting the presence of T2DM. Methods: Forty-eight patients with a new clinical diagnosis of T2DM (n=15), prediabetes (n=17), or NGT (n=16) were included and underwent abdominal magnetic resonance imaging (MRI) scanning with the iterative decomposition of water and fat with echo asymmetry and least square estimation image quantification (IDEAL-IQ) sequencing. VATV was obtained at the level of the 2nd and 3rd lumbar vertebral bodies (VATV L2 and VATV L3) where the sum of VATV L2 and VATV L3 (total VATV) were computed, respectively. Also, pancreatic and hepatic fat content was quantified by measuring the PDFF. The receiver operating characteristic (ROC) curve and binary logistics regression model analysis were employed to evaluate their ability to predict the presence of T2DM. Results: The VATV L2, VATV L3, and total VATV values of the T2DM group were significantly higher than the prediabetes and NGT groups (P0.05). The ROC curve showed the areas under the curve for VATV L2, VATV L3, total VATV, hepatic PDFF, and pancreatic PDFF were 0.76, 0.80, 0.80, 0.79, and 0.75, respectively, in predicting the presence of T2DM (P0.05). The binary logistics regression model analysis revealed that only VATV L3 was independently associated with the incidence of T2DM (P=0.01 and OR =1.01). The sensitivity, specificity, and total accuracy were 80.00%, 88.20%, and 84.40%, respectively. Conclusions: Compared with hepatic PDFF, pancreatic PDFF, VAVT L2, and total VATV, VAVT L3 was the better predictor of T2DM.
- 1 June 2019
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 9 (6) , 1076-1086
Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of visceral abdominal adiposity tissue volume
Background: The correlation between visceral adipose tissue volume (VATV), hepatic proton-density fat fraction (PDFF), and pancreatic PDFF has been previously studied to predict the presence of type 2 diabetes mellitus (T2DM). This study investigated VATV quantitation in patients with T2DM, prediabetes, and normal glucose tolerance (NGT) using MRI to assess the roles of VATV, hepatic, and pancreatic PDFF in predicting the presence of T2DM. Methods: Forty-eight patients with a new clinical diagnosis of T2DM (n=15), prediabetes (n=17), or NGT (n=16) were included and underwent abdominal magnetic resonance imaging (MRI) scanning with the iterative decomposition of water and fat with echo asymmetry and least square estimation image quantification (IDEAL-IQ) sequencing. VATV was obtained at the level of the 2nd and 3rd lumbar vertebral bodies (VATV L2 and VATV L3) where the sum of VATV L2 and VATV L3 (total VATV) were computed, respectively. Also, pancreatic and hepatic fat content was quantified by measuring the PDFF. The receiver operating characteristic (ROC) curve and binary logistics regression model analysis were employed to evaluate their ability to predict the presence of T2DM. Results: The VATV L2, VATV L3, and total VATV values of the T2DM group were significantly higher than the prediabetes and NGT groups (P0.05). The ROC curve showed the areas under the curve for VATV L2, VATV L3, total VATV, hepatic PDFF, and pancreatic PDFF were 0.76, 0.80, 0.80, 0.79, and 0.75, respectively, in predicting the presence of T2DM (P0.05). The binary logistics regression model analysis revealed that only VATV L3 was independently associated with the incidence of T2DM (P=0.01 and OR =1.01). The sensitivity, specificity, and total accuracy were 80.00%, 88.20%, and 84.40%, respectively. Conclusions: Compared with hepatic PDFF, pancreatic PDFF, VAVT L2, and total VATV, VAVT L3 was the better predictor of T2DM.
- Open Access
- 18 April 2019
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-10
Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation
Our aim of the study is to investigate the feasibility of preoperative prediction for hepatocellular carcinoma (HCC) histological grading using gadoxetic acid-enhanced magnetic resonance imaging (MRI). This study included one hundred and fifty-six patients with solitary HCC. Preoperative gadoxetic acid-enhanced MRI findings were retrospectively analyzed. MRI qualitative features such as tumor size, margin, capsule status, signal homogeneity, intratumoral vessels, peritumoral enhancement during mid-arterial phase, peritumoral hypointensity during the hepatobiliary phase (HBP) were investigated. Apparent diffusion coefficients (ADCs), T1 reduction ratio of pre- and post-contrast enhanced images of the tumors were calculated. HCC histological grading in surgical specimens were confirmed by Edmonson’s criteria. Correlations between these MRI features and HCC histological grading were analyzed using multivariate logistic regression. The receiver operating characteristic (ROC) curve was used to assess the predictive efficacy of the model. Univariate analysis showed that maximum tumor diameter (p = 0.004), tumor margin (p = 0.006), intratumoral vessels (p = 0.001) and peritumoral hypointensity during HBP (p = 0.000), were significantly correlated with HCC histological grading. There was no relationship between capsule, tumor signal, venous thrombosis, peritumoral enhancement during mid-arterial phase, ADC value, T1 reduction ratio, and HCC histological grading. Multivariate logistic regression analysis demonstrated that the maximum tumor diameter (p = 0.012, odds ratio = 1.002, 95% confidence interval: 1.007–1.046)) was an independent risk factor for high grade HCC. Greater tumor size, a more irregular margin, presence of intratumoral vessels, and peritumoral hypointensity during HBP were indicators for high grade HCC. The maximum tumor diameter was an independent risk factor for high grade HCC.
- 18 April 2019
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-10
Open AccessImaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation
Our aim of the study is to investigate the feasibility of preoperative prediction for hepatocellular carcinoma (HCC) histological grading using gadoxetic acid-enhanced magnetic resonance imaging (MRI). This study included one hundred and fifty-six patients with solitary HCC. Preoperative gadoxetic acid-enhanced MRI findings were retrospectively analyzed. MRI qualitative features such as tumor size, margin, capsule status, signal homogeneity, intratumoral vessels, peritumoral enhancement during mid-arterial phase, peritumoral hypointensity during the hepatobiliary phase (HBP) were investigated. Apparent diffusion coefficients (ADCs), T1 reduction ratio of pre- and post-contrast enhanced images of the tumors were calculated. HCC histological grading in surgical specimens were confirmed by Edmonson’s criteria. Correlations between these MRI features and HCC histological grading were analyzed using multivariate logistic regression. The receiver operating characteristic (ROC) curve was used to assess the predictive efficacy of the model. Univariate analysis showed that maximum tumor diameter (p = 0.004), tumor margin (p = 0.006), intratumoral vessels (p = 0.001) and peritumoral hypointensity during HBP (p = 0.000), were significantly correlated with HCC histological grading. There was no relationship between capsule, tumor signal, venous thrombosis, peritumoral enhancement during mid-arterial phase, ADC value, T1 reduction ratio, and HCC histological grading. Multivariate logistic regression analysis demonstrated that the maximum tumor diameter (p = 0.012, odds ratio = 1.002, 95% confidence interval: 1.007–1.046)) was an independent risk factor for high grade HCC. Greater tumor size, a more irregular margin, presence of intratumoral vessels, and peritumoral hypointensity during HBP were indicators for high grade HCC. The maximum tumor diameter was an independent risk factor for high grade HCC.
- Open Access
- 1 January 2019
- Published by XMLink in Korean Journal of Radiology
- Vol. 20 (3) , 429-437
MRI T2-Weighted Imaging and Fat-Suppressed T2-Weighted Imaging Image Fusion Technology Improves Image Discriminability for the Evaluation of Anal Fistulas
Feng ST, et al. Korean J Radiol. 2019 Mar;20(3):429-437. https://doi.org/10.3348/kjr.2018.0260
- 1 January 2019
- Published by XMLink in Korean Journal of Radiology
- Vol. 20 (3) , 429-437
Open AccessMRI T2-Weighted Imaging and Fat-Suppressed T2-Weighted Imaging Image Fusion Technology Improves Image Discriminability for the Evaluation of Anal Fistulas
Feng ST, et al. Korean J Radiol. 2019 Mar;20(3):429-437. https://doi.org/10.3348/kjr.2018.0260
- 13 December 2018
- Published by Springer Nature in European Radiology
- Vol. 29 (5) , 2272-2282
Prediction of sorafenib treatment–related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation
To investigate the feasibility of prediction for targeted therapy-related gene expression in hepatocellular carcinoma (HCC) using preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI).
- 13 December 2018
- Published by Springer Nature in European Radiology
- Vol. 29 (5) , 2272-2282
Prediction of sorafenib treatment–related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation
To investigate the feasibility of prediction for targeted therapy-related gene expression in hepatocellular carcinoma (HCC) using preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI).
- Open Access
- 9 November 2018
- Published by Springer Nature in BMC Gastroenterology
- Vol. 18 (1) , 173
CT Enterography score: a potential predictor for severity assessment of active ulcerative colitis
Evaluate the possibility of CT enterography (CTE) score system as a predictor in assessing active ulcerative colitis (UC) severity. Forty-six patients with active UC with CTE and colonoscopy were enrolled. Based on modified Mayo score, patients were divided into three groups: mild (n = 10), moderate (n = 17) and severe (n = 19). A cumulative CTE score was calculated in each patient and its correlation with modified Mayo score was analyzed. The optimal cutoff values of CTE score were determined by receiver operating characteristic (ROC) curves analysis. Significant between-group differences were observed in CTE spectrums of mucosal bubbles, mural stratification, loss of haustration, enlarged mesenteric lymph nodes and engorged mesenteric vessels (P < 0.05). The cumulative CTE scores were significant difference between three groups (CTE score:4.9 ± 2.3, 7.6 ± 2.6, and 10.9 ± 2.0, respectively, P < 0.01). The cumulative CTE score showed a positive correlation with modified Mayo score (r = 0.835, P < 0.05). The optimal cut-off value for CTE score predicting moderate and severe UC was 9.5 (area under the curve [AUC]:0.847, sensitivity:78.9%, specificity:82.4%). Disease severity assessment by CTE score demonstrates strong positive correlation with severity established modified Mayo score. CTE score system maybe a potential predictor for active UC severity assessment.
- 9 November 2018
- Published by Springer Nature in BMC Gastroenterology
- Vol. 18 (1) , 173
Open AccessCT Enterography score: a potential predictor for severity assessment of active ulcerative colitis
Evaluate the possibility of CT enterography (CTE) score system as a predictor in assessing active ulcerative colitis (UC) severity. Forty-six patients with active UC with CTE and colonoscopy were enrolled. Based on modified Mayo score, patients were divided into three groups: mild (n = 10), moderate (n = 17) and severe (n = 19). A cumulative CTE score was calculated in each patient and its correlation with modified Mayo score was analyzed. The optimal cutoff values of CTE score were determined by receiver operating characteristic (ROC) curves analysis. Significant between-group differences were observed in CTE spectrums of mucosal bubbles, mural stratification, loss of haustration, enlarged mesenteric lymph nodes and engorged mesenteric vessels (P < 0.05). The cumulative CTE scores were significant difference between three groups (CTE score:4.9 ± 2.3, 7.6 ± 2.6, and 10.9 ± 2.0, respectively, P < 0.01). The cumulative CTE score showed a positive correlation with modified Mayo score (r = 0.835, P < 0.05). The optimal cut-off value for CTE score predicting moderate and severe UC was 9.5 (area under the curve [AUC]:0.847, sensitivity:78.9%, specificity:82.4%). Disease severity assessment by CTE score demonstrates strong positive correlation with severity established modified Mayo score. CTE score system maybe a potential predictor for active UC severity assessment.
- Open Access
- 25 October 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Combined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis
Objective. We propose a computer-aided method to assess response to drug treatment, using CT imaging-based volumetric and density measures in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and diffuse liver metastases. Methods. Twenty-five patients with GEP-NETs with diffuse liver metastases were enrolled. Pre- and posttreatment CT examinations were retrospectively analyzed. Total tumor volume (volume) and mean volumetric tumor density (density) were calculated based on tumor segmentation on CT images. The maximum axial diameter (tumor size) for each target tumor was measured on pre- and posttreatment CT images according to Response Evaluation Criteria In Solid Tumors (RECIST). Progression-free survival (PFS) for each patient was measured and recorded. Results. Correlation analysis showed inverse correlation between change of volume and density (Δ(V + D)), change of volume (ΔV), and change of tumor size (ΔS) with PFS (r = −0.653, ; r = −0.617, ; r = −0.548, , respectively). There was no linear correlation between ΔD and PFS (r = −0.226, ). Conclusion. The changes of volume and density derived from CT images of all lesions showed a good correlation with PFS and may help assess treatment response.- 25 October 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Open AccessCombined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis
Objective. We propose a computer-aided method to assess response to drug treatment, using CT imaging-based volumetric and density measures in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and diffuse liver metastases. Methods. Twenty-five patients with GEP-NETs with diffuse liver metastases were enrolled. Pre- and posttreatment CT examinations were retrospectively analyzed. Total tumor volume (volume) and mean volumetric tumor density (density) were calculated based on tumor segmentation on CT images. The maximum axial diameter (tumor size) for each target tumor was measured on pre- and posttreatment CT images according to Response Evaluation Criteria In Solid Tumors (RECIST). Progression-free survival (PFS) for each patient was measured and recorded. Results. Correlation analysis showed inverse correlation between change of volume and density (Δ(V + D)), change of volume (ΔV), and change of tumor size (ΔS) with PFS (r = −0.653, ; r = −0.617, ; r = −0.548, , respectively). There was no linear correlation between ΔD and PFS (r = −0.226, ). Conclusion. The changes of volume and density derived from CT images of all lesions showed a good correlation with PFS and may help assess treatment response. - 6 June 2018
- Published by Springer Nature in European Radiology
- Vol. 28 (12) , 5250-5257
CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?
To identify a reliable early indicator of deriving progression-free survival (PFS) benefit in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with octreotide long-acting repeatable (LAR).
- 6 June 2018
- Published by Springer Nature in European Radiology
- Vol. 28 (12) , 5250-5257
CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?
To identify a reliable early indicator of deriving progression-free survival (PFS) benefit in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with octreotide long-acting repeatable (LAR).
- Open Access
- 23 January 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-9
Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced MRI and Histopathological Correlation
Objective. To investigate the imaging features observed in preoperative Gd-EOB-DTPA-dynamic enhanced MRI and correlated with the presence of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) patients. Methods. 66 HCCs in 60 patients with preoperative Gd-EOB-DTPA-dynamic enhanced MRI were retrospectively analyzed. Features including tumor size, signal homogeneity, tumor capsule, tumor margin, peritumor enhancement during mid-arterial phase, peritumor hypointensity during hepatobiliary phase, signal intensity ratio on DWI and apparent diffusion coefficients (ADC), T1 relaxation times, and the reduction rate between pre- and postcontrast enhancement images were assessed. Correlation between these features and histopathological presence of MVI was analyzed to establish a prediction model. Results. Histopathology confirmed that MVI were observed in 17 of 66 HCCs. Univariate analysis showed tumor size (), margin (), peritumor enhancement (), and hypointensity during hepatobiliary phase () were associated with MVI. A multiple logistic regression model was established, which showed tumor size, margin, and peritumor enhancement were combined predictors for the presence of MVI (). of this prediction model was 0.353, and the sensitivity and specificity were 52.9% and 93.0%, respectively. Conclusion. Large tumor size, irregular tumor margin, and peritumor enhancement in preoperative Gd-EOB-DTPA-dynamic enhanced MRI can predict the presence of MVI in HCC.- 23 January 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-9
Open AccessPrediction of Microvascular Invasion in Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced MRI and Histopathological Correlation
Objective. To investigate the imaging features observed in preoperative Gd-EOB-DTPA-dynamic enhanced MRI and correlated with the presence of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) patients. Methods. 66 HCCs in 60 patients with preoperative Gd-EOB-DTPA-dynamic enhanced MRI were retrospectively analyzed. Features including tumor size, signal homogeneity, tumor capsule, tumor margin, peritumor enhancement during mid-arterial phase, peritumor hypointensity during hepatobiliary phase, signal intensity ratio on DWI and apparent diffusion coefficients (ADC), T1 relaxation times, and the reduction rate between pre- and postcontrast enhancement images were assessed. Correlation between these features and histopathological presence of MVI was analyzed to establish a prediction model. Results. Histopathology confirmed that MVI were observed in 17 of 66 HCCs. Univariate analysis showed tumor size (), margin (), peritumor enhancement (), and hypointensity during hepatobiliary phase () were associated with MVI. A multiple logistic regression model was established, which showed tumor size, margin, and peritumor enhancement were combined predictors for the presence of MVI (). of this prediction model was 0.353, and the sensitivity and specificity were 52.9% and 93.0%, respectively. Conclusion. Large tumor size, irregular tumor margin, and peritumor enhancement in preoperative Gd-EOB-DTPA-dynamic enhanced MRI can predict the presence of MVI in HCC.